ferric citrate Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4538 3522-50-7

Description:

MoleculeDescription

Synonyms:

  • fexeric
  • ferric citrate hydrate
  • ferric citrate
  • ferric citrate trihydrate
  • Molecular weight: 244.94
  • Formula: C6H5FeO7
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 99.13
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
6 g O

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Sept. 5, 2014 FDA KERYX BIOPHARMS

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC V03AE08 VARIOUS
ALL OTHER THERAPEUTIC PRODUCTS
ALL OTHER THERAPEUTIC PRODUCTS
Drugs for treatment of hyperkalemia and hyperphosphatemia
CHEBI has role CHEBI:50733 nutritional supplement
CHEBI has role CHEBI:75835 antianemia drug

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hyperphosphatemia indication 20165001 DOID:0050459

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D09993 KEGG_DRUG
4033763 VUID
N0000191091 NUI
17217-76-4 SECONDARY_CAS_RN
4033763 VANDF
C0060231 UMLSCUI
CHEBI:144421 CHEBI
CHEMBL3301597 ChEMBL_ID
CHEMBL3991241 ChEMBL_ID
DB14520 DRUGBANK_ID
C025314 MESH_SUPPLEMENTAL_RECORD_UI
756B6D74H4 UNII
61300 PUBCHEM_CID
1594675 RXNORM
30829 MMSL
d08336 MMSL
007462 NDDF
763035003 SNOMEDCT_US
764380003 SNOMEDCT_US

Pharmaceutical products:

None